ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $921,557 | -14.1% | 32,901 | -4.0% | 0.01% | -14.3% |
Q2 2023 | $1,072,588 | +10.3% | 34,268 | -0.6% | 0.01% | +16.7% |
Q1 2023 | $972,301 | -8.2% | 34,491 | -14.9% | 0.01% | 0.0% |
Q4 2022 | $1,059,232 | +68.1% | 40,537 | +43.6% | 0.01% | +100.0% |
Q3 2022 | $630,000 | -28.7% | 28,226 | -4.8% | 0.00% | -25.0% |
Q2 2022 | $883,000 | +21.6% | 29,653 | +7.4% | 0.00% | +33.3% |
Q1 2022 | $726,000 | +61.3% | 27,612 | +42.8% | 0.00% | 0.0% |
Q4 2021 | $450,000 | -13.6% | 19,332 | +14.5% | 0.00% | 0.0% |
Q3 2021 | $521,000 | +30.2% | 16,883 | +3.6% | 0.00% | 0.0% |
Q2 2021 | $400,000 | – | 16,294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
Birchview Capital, LP | 35,000 | $654,000 | 0.39% |